Skip to main content

Please read:

Effective October 1, 2024, our Quest Diagnostics Patient Navigators solution will replace our online cost estimating tool, known as the QNatal® Cost Estimator. Our goal is to provide our patients with the most accurate, complete estimates possible for our QNatal® Advanced noninvasive prenatal screening. For a personalized out-of-pocket estimate, including discussion of possible financial assistance where appropriate, please contact our Patient Navigator team via email at patientnavigators@questdiagnostics.com, or by calling 1 (888) 445-5011.

Hide

Live your healthiest life

Whether you’re focused on protecting your sexual health, planning a family, or taking control of your overall wellness, your healthcare journey is unique. We make it easier for you and your primary care physician, obstetrician, or gynecologist to get testing, support, and answers you can trust. 

  • Breast cancer                       
  • Cervical cancer
  • Colorectal cancer
  • Fertility
  • Genetic screening
  • Heart health
  • Hereditary cancer
  • Pregnancy screening
  • Sexually transmitted infection
  • Wellness

With approximately 2,000 Patient Service Centers nationwide, we provide convenient access to testing through every stage of your life. This can include tests for fertility or for each pregnancy trimester, a broad range of STI tests, and many other tests for your annual wellness exam. We may be able to collect your sample in the privacy of your home or office; check if this is available for purchase in your area through Quest Mobile™.

Your well-woman visit

Your well-woman visit, also known as an annual wellness exam, is an important part of maintaining overall wellness and minimizing health risks. From routine screening at every age to tests for STIs, we can help you and your doctor make more informed decisions. Our age-based screenings are based on guidelines to ensure you get the right test at the right time.

 

Your doctor will advise you on the age at which you should begin annual screening

  • Annual chlamydia and gonorrhea testing (if sexually active)
  • Human immunodeficiency virus (HIV) testing (if sexually active)b
  • Screening for trichomonas (when risk factors are identified)c
  • Annual chlamydia and gonorrhea testing (under 25 and if sexually active and for older women who are at increased risk for infection)a
  • Cervical cancer screening recommended to start at age 21
  • Human immunodeficiency virus (HIV) testing (if sexually active)b
  • Screening for trichomonas (when risk factors are identified)c
  • Diabetes testing every 3 years after age 4
  • Cervical cancer screening
  • Lipid profile assessment every 5 years beginning at age 4
  • Thyroid-stimulating hormone testing every 5 years beginning at age 5
  • Colorectal cancer screening
  • Human immunodeficiency virus (HIV) testing
  • One-time hepatitis C testing for persons born from 1945 through 1965 and unaware of their infection status (more often for high-risk patients)
  • Screening for chlamydia, gonorrhea, and trichomonas (when risk factors are identifiedc)

Getting candid about HPV and cervical cancer

Take control of your health when it comes to cervical cancer and HPV.

Read the article

Pregnant or planning to become pregnant?

Your path to pregnancy is your own, and we support every step of the journey. Whether you’re planning a family or want to understand your potential genetic risks, knowing feels better.

We offer genetic screening that can help you understand potential risks, so you and your doctor can make informed decisions about your and your baby’s well-being.

If you or your partner are facing infertility, we can help provide you and your doctor with insights so you can develop the best plan.

ReproSource® is a highly specialized diagnostic laboratory focused exclusively on helping couples find answers to their fertility challenges.g Ask your doctor if fertility testing is an option for you.

It's okay to talk about STIs

Whether you are experiencing symptoms or are simply at a higher risk, screening for genital tract infections including sexually transmitted infections (STIs)—also called sexually transmitted diseases (STDs)—is available at all stages of life. We offer a comprehensive test menu to help you protect your health.

 

  • Chlamydia
  • Gonorrhea
  • Mycoplasma genitalium
  • Vaginitis
  • Cervicitis
  • Pelvic inflammatory disease
  • Herpes
  • Syphilis

 

Talk to your doctor about the importance of screening for STIs.

OBGYN Patient LP

Frequently asked questions

About billing

Quest is in-network with most major health plans including UnitedHealthcare, Aetna®, Humana®, Cigna®, and most Anthem® and Blue Cross® Blue Shield® plans—just to name a few.

Our Patient Navigators are dedicated billing specialists trained to answer questions about Quest genetic testing, and they’ll help navigate any necessary prior authorizations for Quest prenatal genetic screenings.

1.888.445.5011


PatientNavigators@QuestDiagnostics.com

Your out-of-pocket cost for screening will depend on your insurance, and our Patient Navigators will help ensure you know what your costs will be.

Contact a Patient Navigator


1.888.445.5011


PatientNavigators@QuestDiagnostics.com

 

Our flexible and easy-to-use financial assistance programs can help cover the costs for noninvasive prenatal screening and advanced genetic screening.h Depending on the number of people in your household and the total household income, you may be eligible to receive screening and pay no fee ($0) or a reduced fee no greater than $200.

 

A Patient Navigator can help you understand what financial assistance options may be available to you.

1.888.445.5011


PatientNavigators@QuestDiagnostics.com 

About test results

Our Genomic Science Specialists are available to talk directly with you about your QHerit or QNatal genetic test results, so you and your doctor can take the next steps.

1.866.GENE.INFO (1.866.436.3463) Monday-Friday, 8:30 AM–8:00 PM EST

Talk to your doctor about how Quest can help support your healthiest life

Positive results may need to be reported to the authorities under applicable law. Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit and search for Well-Woman Recommendations.

Healthcare providers should always follow state HIV screening requirements. For more information, visit and search for the September 22, 2006 issue of MMWR™ Recommendations and Reports.

The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection

Important information


QNatal® Advanced is a cell-free DNA test that screens for increased risk of certain fetal chromosomal abnormalities that may cause birth defects, including trisomy 21 (Down Syndrome), trisomy 18, trisomy 13, and certain sex chromosome abnormalities (ie, 45,X, 47,XXY, 47,XXX, and 47,XYY). In addition, if selected as an option, QNatal Advanced can screen for certain microdeletions (ie, 22q, 5p, 1p36, 15q, 11q, 8q, and 4p) that may cause birth defects, and/or for fetal sex. This test does not assess the risk of fetal anomalies such as neural tube defects or ventral wall defects. QNatal Advanced must not be used earlier than 10 weeks into pregnancy.

QNatal is a “screening” test, not a diagnostic test, and therefore all positive/increased risk results should be followed by genetic counseling and further diagnostic testing and procedures, when clinically indicated. Pregnancy management decisions should not be based on the results of a cfDNA test alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic marker, and may be lower for rare conditions. Performance data for the QNatal Advanced test may be obtained by contacting Quest Diagnostics at 1.866.GENE.INFO (1.866.436.3463). QNatal Advanced is a laboratory developed test that has been developed and validated, pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA), and as such it has not been reviewed by FDA.

QHerit®, QHerit Plus, QHerit Extended, QHerit 421, QHerit 381, QHerit 445, and QHerit 400 are carrier “screening” tests, and they screen for variations in genes linked to certain health disorders which can be passed from parents to children. QHerit screens 24 genes; QHerit Plus screens 85 genes; QHerit Extended screens 150 genes; QHerit 421 screens 421 genes; QHerit 381 screens 381 genes; QHerit 445 screens 445 genes; and QHerit 400 screens 400 genes. For a full list of genes that each panel in the QHerit family screens, visit QHerit.com. If the results from any panel in the QHerit family suggest that a patient may be a carrier of a gene variation that can cause a health disorder in offspring, it is recommended that the reproductive partner be offered genetic screening, and that genetic counseling be provided for both partners. Pregnancy management decisions should not be based on the results of these screening tests alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation and may be lower for rare conditions.Patients should discuss with their provider reproductive implications and the need for further testing based on screening results.Each panel in the QHerit family is a laboratory-developed test that has been developed and validated pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA) and, as such, have not been reviewed by the FDA.

Based on full year 2023 claims analysis.

Based on full year 2022 claims analysis.

ReproSource is a national leader in specialty fertility diagnostic services. While ReproSource is a Quest Diagnostics affiliate, ReproSource and Quest are separate companies. As such, health plan access, test ordering, and billing processes may differ from those of Quest Diagnostics. Please note ReproSource is not a Medicare/Medicaid provider. For more information, please contact ReproSource at 1.800.667.8893 or visit ReproSource.com/Contact.

Our Supplemental Financial Assistance Program (SFAP) is a unique program available for QNatal and QHerit only. For all other tests, patients that qualify may access our standard financial assistance program.

The household income (HHI) criteria provided are based upon the US Department of Health and Human Services Guidelines for 2024. The guidelines are updated annually and are available at the HHS website (https://ASPE.HHS.gov/Poverty-Guidelines). Quest Diagnostics reserves the right to modify or terminate this program at any time.

Reference

  1. Women’s Preventive Services Initiative. Recommendations for well-woman care - well-woman chart. Updated 2024. Accessed May 16, 2024. https://www.womenspreventivehealth.org/wellwomanchart/

Talk to your doctor about ways to stay well 

For convenient and affordable testing, it's easy to schedule a time and place with Quest. 

Book now